Aperio Group’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Aperio Group’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-20,867	Closed	-$260K	–	2209
2016 Q4	$260K	Sell	20,867 -2,879	-12%	-$34.7K	﹤0.01%	1863
2016 Q3	$325K	Buy	23,746 +576	+2%	+$5.78K	﹤0.01%	1673
2016 Q2	$171K	Sell	23,170 -6,678	-22%	-$50.1K	﹤0.01%	1904
2016 Q1	$191K	Sell	29,848 -19,118	-39%	-$107K	﹤0.01%	1887
2015 Q4	$306K	Sell	48,966 -2,834	-5%	-$18.6K	﹤0.01%	1613
2015 Q3	$303K	Buy	51,800 +16	+0%	+$123	﹤0.01%	1560
2015 Q2	$428K	Buy	51,784 +6,533	+14%	+$57.8K	﹤0.01%	1420
2015 Q1	$373K	Sell	45,251 -1,095	-2%	-$8.1K	﹤0.01%	1433
2014 Q4	$318K	Buy	46,346 +5,005	+12%	+$31.3K	﹤0.01%	1468
2014 Q3	$223K	Buy	41,341 +13,167	+47%	+$76.9K	﹤0.01%	1545
2014 Q2	$179K	Sell	28,174 -8,375	-23%	-$57.6K	﹤0.01%	1637
2014 Q1	$295K	Buy	+36,549	New	+$285K	﹤0.01%	1638
2013 Q4	–	Hold	0	–	–	–	1881

Other funds holding ARIA

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Aperio Group's ARIA Position: Q1 2017 in Review

Aperio Group sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 20,867 shares — an estimated $260K sold.

Aperio Group first reported a position in ARIA in Q1 2014 and held it in 12 quarters. The position peaked at $428K in Q2 2015. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

Aperio Group reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
Aperio Group sold 20,867 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $260K.
Aperio Group first reported a position in Ariad Pharmaceuticals Inc in Q1 2014 and held it in 12 quarters.
Aperio Group's Ariad Pharmaceuticals Inc position peaked at $428K in Q2 2015.
1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Aperio Group's 13F filing for Q1 2017, filed 5 May 2017.